Innovid Launches Social Automation Solution to Power Performance across Platforms
The launch marks a significant advancement in paid social automation. Brands and agencies can now manage and optimize campaigns in real time across social platforms – with early adopters reporting a 22% lift in ROAS vs. native social tools.
Share
The launch marks a significant advancement in paid social automation. Brands and agencies can now manage and optimize campaigns in real time across platforms like Meta, TikTok, Snapchat, Pinterest, and LinkedIn – with early adopters reporting a 22% lift in ROAS vs. native social tools.
Automate with greater control and flexibility: Build logic-based rules using time ranges, Boolean logic, and multiple conditions – all within a streamlined workflow.
Power advanced cross-platform automation: Apply custom rules across all publishers and campaign entities at once – with full control over timing, triggers, and conditions.
Sync messaging to real-time sports moments: Trigger ads based on key live events like game start times, scores, overtime, or custom team and player signals – ensuring relevance when fans are the most engaged.
Leverage weather-based optimization at scale: Automatically adjust messaging based on live weather conditions – from temperature and precipitation to severe alerts – and configure rules by city, region, or condition type.
'We built this solution to meet a growing need for smarter, scalable social campaign management,' said Zak Knudson, SVP, Product Management, Innovid. 'Marketers no longer have to choose between scale and precision – with our automation engine, they get both.'
About Innovid
Innovid is the leading independent ad tech platform, empowering marketers to create, deliver, measure, and optimize ad-supported experiences that people love. In 2025, Innovid and Flashtalking merged to create a transparent, scalable alternative to big-tech, walled-garden, and point solutions across CTV, digital, linear, and social channels. As part of Mediaocean, Innovid is tied into the industry's core ad infrastructure for omnichannel planning, buying, and billing. Visit www.innovid.com to learn more.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
22 minutes ago
- Business Wire
Prodapt Announces Strategic Expansion in Alberta Through Partnership with Invest Alberta
DALLAS & CHENNAI, India--(BUSINESS WIRE)--Prodapt, a global leader in telecom-native services and AI-driven transformation, has signed a Memorandum of Understanding (MOU) with Invest Alberta to expand its operations in the province. This strategic partnership marks a significant step in Prodapt's North America growth strategy, with plans to deliver more than $100 million in economic impact in Alberta over five years. 'Invest Alberta's collaboration with Prodapt represents another step toward making Alberta a hub for innovation in AI and technology investments in Alberta. Their confidence in what Alberta has to offer is an indication that our province is going in the right direction in growing a cutting-edge tech ecosystem that signals to the world that we are ready for this kind of expansion. Prodapt's trust and collaboration help bring Alberta to the world, and equip our investors to develop global solutions based on AI technology,' says Rick Christiaanse, CEO of Invest Alberta. Prodapt's expansion includes establishing a nearshore delivery center to serve North American clients, with a focus on AI, cloud, and digital transformation. The company will collaborate with Alberta's leading universities to develop AI consulting and advisory services, specializing in Sovereign AI, GenAI platforms, and next-generation software engineering. 'This expansion represents more than just growth — it's a commitment to building lasting partnerships in one of North America's most ambitious innovation ecosystems,' said Manish Vyas, CEO of Prodapt. 'We're excited to collaborate with government, academia, and local businesses to advance the future of technology and deliver meaningful impact across Alberta.' Accelerating Digital Transformation in Western Canada Rajiv Papneja, Chief Technology Officer at Prodapt, noted: 'Alberta serves as a catalyst for our vision around Sovereign AI and next-gen platform engineering. With strong university ecosystems and a government focused on digital innovation, we're positioned to co-create solutions in AI, automation, and cloud that will benefit both Canada and global markets.' This initiative supports Alberta's strategic shift toward technology, clean energy, and AI-driven innovation, creating high-value opportunities for local talent and businesses. The university collaboration will include co-creating AI programs, offering real-world consulting projects, and developing a skilled workforce for tech roles. Strengthening Local Talent and Innovation The partnership strengthens Alberta's innovation landscape while positioning the province as a competitive destination for global technology investment. 'The support from Invest Alberta underscores our shared belief in Alberta's potential as a technology and talent hub. This MOU lays the foundation for a nearshore delivery center that will serve our North American clients, while fostering innovation through close collaboration with local universities and government programs,' said Sricharan Kuppam, Canada country head, Prodapt. 'As the province's engine for innovation, Alberta Innovates sees this MOU between Invest Alberta and Prodapt, as a big step forward for growing tech in Alberta,' says Mike Mahon, CEO Alberta Innovates. 'International partnerships like these are the key to diversifying and growing our economy. We couldn't be happier to welcome Prodapt to the ecosystem.' About Prodapt Prodapt is the largest specialized player in the Connectedness industry. As an AI-first strategic technology partner, Prodapt provides consulting, business reengineering, and managed services for the largest telecom and tech enterprises building networks and digital experiences of tomorrow. A ServiceNow-invested company, Prodapt has been recognized by Gartner as a Large, Telecom-Native, Regional IT Service Provider. Connecting 1.1 billion people and 5.4 billion devices across the globe, Prodapt's clients include Rogers, Telus, Verizon, Vodafone, Liberty Global, Liberty Latin America, Claro, Lumen, Windstream, KPN, Virgin Media, British Telecom, Deutsche Telekom, Google, Amazon, PayPal, SoftBank, ServiceNow, Ciena, Adtran, Samsung and many more. A 'Great Place To Work® Certified™' company, Prodapt employs over 6,000 technology and domain experts across the Americas, Europe, India, Africa, & Japan. Prodapt is part of the 130-year-old business conglomerate The Jhaver Group, which employs over 32,000 people across 80+ locations globally.
Business Upturn
23 minutes ago
- Business Upturn
Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression
Business Wire India Revenue Decline of 3.7% at Constant Exchange Rate (CER); 8.4% Decline at Actual Exchange Rates (AER) as VYVANSE®Generic Erosion Impacts Revenue in Line With Company Expectations Core Operating Profit Decline of 11.9% at CER, Primarily Reflecting Generic Erosion Reported Operating Profit Increase of 11.0% at AER, Reflecting Lower YoY Impairment and Restructuring Expenses Positive Results from Two Pivotal Phase 3 Studies of Oveporexton in Narcolepsy Type 1 Reinforce Continued Momentum in Late-Stage Pipeline No Change to Full-Year Outlook Announced in May Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the first quarter of fiscal year 2025 (three months ended June 30, 2025), with generic erosion of VYVANSE significantly impacting revenue and Core Operating Profit in line with company expectations for the quarter. The company expects these impacts to moderate in future quarters. Takeda also achieved several important milestones in its R&D pipeline, reinforcing its long-term growth trajectory and underscoring its commitment to delivering sustainable value through innovation. Most notably, both Phase 3 studies of oveporexton successfully met all primary and secondary endpoints, demonstrating statistically significant improvements across doses. These results reinforce the potential of oveporexton to transform the standard of care in narcolepsy type 1. In addition, Takeda received U.S. FDA approval for GAMMAGARD® LIQUID ERC and European Commission (EC) approval for ADCETRIS® in new indications and presented promising clinical data for rusfertide at the 61st American Society of Clinical Oncology (ASCO) Annual Meeting Plenary Session. These developments underscore the strength of Takeda's late-stage pipeline and its potential to drive future growth. Takeda chief financial officer, Milano Furuta, commented: 'The impact of VYVANSE generic erosion on Takeda's FY2025 Q1 results was very significant, but consistent with our expectations, and there is no change to our full-year outlook announced in May. 'Our late-stage pipeline continues to advance with the announcement in July of positive results from two pivotal Phase 3 studies for oveporexton in narcolepsy type 1, with both studies meeting all primary and secondary endpoints. These results represent a significant scientific milestone, and we are very excited about the potential for our late-stage pipeline to deliver value to the patients we serve and to position Takeda for sustainable growth.' FINANCIAL HIGHLIGHTS for FY2025 Q1 Ended June 30, 2025 (Billion yen, except percentages and per share amounts) FY2025 Q1 FY2024 Q1 vs. PRIOR YEAR (Actual % change) Revenue 1,106.7 1,208.0 -8.4% Operating Profit 184.6 166.3 +11.0% Net Profit 124.2 95.2 +30.4% EPS (Yen) 79 61 +30.8% Operating Cash Flow 215.4 170.3 +26.5% Adjusted Free Cash Flow (Non-IFRS) 190.1 23.7 +703.6% Core (Non-IFRS) (Billion yen, except percentages and per share amounts) FY2025 Q1 FY2024 Q1 vs. PRIOR YEAR (Actual % change) vs. PRIOR YEAR (CER % change) Revenue 1,106.7 1,208.0 -8.4% -3.7% Operating Profit 321.8 382.3 -15.8 % -11.9% Margin 29.1% 31.6% -2.6 pp ― Net Profit 237.0 276.8 -14.4% -10.3% EPS (Yen) 151 176 -14.1% -10.0% FY2025 Outlook (unchanged from May 2025) (Billion yen, except percentages and per share amounts) FY2025 FORECAST FY2025 MANAGEMENT GUIDANCE Core Change at CER (Non-IFRS) Revenue 4,530.0 — Core Revenue (Non-IFRS) 4,530.0 Broadly flat Operating Profit 475.0 — Core Operating Profit (Non-IFRS) 1,140.0 Broadly flat Net Profit 228.0 — EPS (Yen) 145 — Core EPS (Yen) (Non-IFRS) 485 Broadly flat Adjusted Free Cash Flow (Non-IFRS) 750.0-850.0 — Annual Dividend per Share (Yen) 200 — Additional Information About Takeda's FY2025 Q1 Results For more details about Takeda's FY2025 Q1 results, commercial progress, pipeline updates and other financial information, including key assumptions in the FY2025 forecast and management guidance as well as definitions of non-IFRS measures, please refer to Takeda's FY2025 Q1 investor presentation (available at About Takeda Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit Important Notice For the purposes of this notice, 'press release' means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ('Takeda') regarding this press release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws. The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, 'Takeda' is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words 'we', 'us' and 'our' are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies. The product names appearing in this document are trademarks or registered trademarks owned by Takeda, or their respective owners. Forward-Looking Statements This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda's future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as 'targets', 'plans', 'believes', 'hopes', 'continues', 'expects', 'aims', 'intends', 'ensures', 'will', 'may', 'should', 'would', 'could', 'anticipates', 'estimates', 'projects', 'forecasts', 'outlook' or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda's global business, including general economic conditions in Japan and the United States and with respect to international trade relations; competitive pressures and developments; changes to applicable laws and regulations, including tax, tariff and other trade-related rules; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic; the success of our environmental sustainability efforts, in enabling us to reduce our greenhouse gas emissions or meet our other environmental goals; the extent to which our efforts to increase efficiency, productivity or cost-savings, such as the integration of digital technologies, including artificial intelligence, in our business or other initiatives to restructure our operations will lead to the expected benefits; and other factors identified in Takeda's most recent Annual Report on Form 20-F and Takeda's other reports filed with the U.S. Securities and Exchange Commission, available on Takeda's website at: at does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda's future results. Financial information and Non-IFRS Measures Takeda's financial statements are prepared in accordance with International Financial Reporting Standards ('IFRS'). This press release and materials distributed in connection with this press release include certain financial measures not presented in accordance with IFRS, such as Core Revenue, Core Operating Profit, Core Net Profit for the year attributable to owners of the Company, Core EPS, Constant Exchange Rate ('CER') change, Net Debt, Adjusted Net Debt, EBITDA, Adjusted EBITDA, Free Cash Flow and Adjusted Free Cash Flow. Takeda's management evaluates results and makes operating and investment decisions using both IFRS and non-IFRS measures included in this press release. These non-IFRS measures exclude certain income, cost and cash flow items which are included in, or are calculated differently from, the most closely comparable measures presented in accordance with IFRS. Takeda's non-IFRS measures are not prepared in accordance with IFRS and such non-IFRS measures should be considered a supplement to, and not a substitute for, measures prepared in accordance with IFRS (which we sometimes refer to as 'reported' measures). Investors are encouraged to review the definitions and reconciliations of non-IFRS measures to their most directly comparable IFRS measures, which are in the Financial Appendix appearing at the end of our FY2025 Q1 investor presentation (available at Peak Sales and PTRS Estimates References in this press release to peak revenue potential ranges are estimates that have not been adjusted for probability of technical and regulatory success (PTRS) and should not be considered a forecast or target. These peak revenue potential ranges represent Takeda's assessments of various possible future commercial scenarios that may or may not occur. References in this press release to PTRS are to internal estimates of Takeda regarding the likelihood of obtaining regulatory approval for a particular product in a particular indication. These estimates reflect the subjective judgment of responsible Takeda personnel and have been approved by Takeda's Portfolio Review Committee for use in internal planning. Medical information This press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development. Please refer to slide 6 of Takeda's FY2025 Q1 investor presentation (available at for the definition of Growth & Launch Products. View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash
Associated Press
23 minutes ago
- Associated Press
Australia bans YouTube accounts for children under 16 in reversal of previous stance
MELBOURNE, Australia (AP) — The Australian government announced YouTube will be among the social media platforms that must ensure account holders are at least 16-years-old from December, reversing a position taken months ago on the popular video-sharing service. YouTube was listed as an exemption in November last year when the Parliament passed world-first laws that will ban Australian children younger than 16 from platforms including Facebook, Instagram, Snapchat, TikTok and X. Communications Minister Anika Wells released rules Wednesday that decide which online services are defined as 'age-restricted social media platforms' and which avoid the age limit. The age restrictions take effect Dec. 10 and platforms will face fines of up to 50 million Australian dollars ($33 million) for 'failing to take responsible steps' to exclude underage account holders, a government statement said. The steps are not defined. Wells defended applying the restrictions to YouTube and said the government would not be intimidated by threats of legal action from the platform's U.S. owner, Alphabet Inc. 'The evidence cannot be ignored that four out of 10 Australian kids report that their most recent harm was on YouTube,' Wells told reporters, referring to government research. 'We will not be intimidated by legal threats when this is a genuine fight for the wellbeing of Australian kids.' Children will be able to access YouTube but will not be allowed to have their own YouTube accounts. YouTube said the government's decision 'reverses a clear, public commitment to exclude YouTube from this ban.' 'We share the government's goal of addressing and reducing online harms. Our position remains clear: YouTube is a video sharing platform with a library of free, high-quality content, increasingly viewed on TV screens. It's not social media,' a YouTube statement said, noting it will consider next steps and engage with the government. Prime Minister Anthony Albanese said Australia would campaign at a United Nations forum in New York in September for international support for banning children from social media. 'I know from the discussions I've had with other leaders that they are looking at this and they are considering what impact social media is having on young people in their respective nations,' Albanese said. 'It is a common experience. This is not an Australian experience.' Last year, the government commissioned an evaluation of age assurance technologies that was to report last month on how young children could be excluded from social media. The government had yet to receive that evaluation's final recommendations, Wells said. But she added the platform users won't have to upload documents such as passports and driver's licenses to prove their age. 'Platforms have to provide an alternative to providing your own personal identification documents to satisfy themselves of age,' Wells said. 'These platforms know with deadly accuracy who we are, what we do and when we do it. And they know that you've had a Facebook account since 2009, so they know that you are over 16.' Exempt services include online gaming, messaging, education and health apps. They are excluded because they are considered less harmful to children. The minimum age is intended to address harmful impacts on children including addictive behaviors caused by persuasive or manipulative platform design features, social isolation, sleep interference, poor mental and physical health, low life-satisfaction and exposure to inappropriate and harmful content, government documents say.
